米国株 ファンダメンタル分析US Fundamental Analysis
📋 ソース: Early Stage 2
📋 Source: Early Stage 2
| RS Rating | 81.0 |
| Minervini Score | 9/10 |
| CANSLIM Score | 7/10 |
| EPS Growth | 2641.7% |
| Revenue Growth | 15.0% |
| ROE | 1.6% |
| Sector | Healthcare |
📋 ソース: Early Stage 2
📋 Source: Early Stage 2
| RS Rating | 81.0 |
| Minervini Score | 9/10 |
| CANSLIM Score | 7/10 |
| EPS Growth | 2641.7% |
| Revenue Growth | 15.0% |
| ROE | 1.6% |
| Sector | Healthcare |